Literature DB >> 22593014

Cell surface turnover of the glutamate transporter GLT-1 is mediated by ubiquitination/deubiquitination.

Jaime Martínez-Villarreal1, Noemí García Tardón, Ignacio Ibáñez, Cecilio Giménez, Francisco Zafra.   

Abstract

The main glutamate transporter in the brain, GLT-1, mediates glutamatergic neurotransmission in both physiological and pathological conditions. GLT-1 activity is controlled by both constitutive and regulated trafficking, and although recent evidence indicates that the turnover of this protein in the plasma membrane is accelerated by protein kinase C via an ubiquitin-dependent process, the mechanisms driving the constitutive trafficking of GLT-1 remain unexplored. Here, we used a heterologous system and primary astrocytes to investigate the turnover of GLT-1 and the role of ubiquitin attachment in this process. We show that GLT-1 is endocytosed constitutively in a clathrin-dependent manner, recycling the transporter into endosomes containing EEA1 and Rab4, a marker of rapidly recycling endosomes, and not Rab11 or Rab7, markers of the slow recycling and late endosomal compartments, respectively. We also show that this process is dependent on ubiquitination, because the inhibitor of the ubiquitin-activating enzyme E1, 4[4-(5-nitro-furan-2-ylmethylene)-3,5-dioxo-pyrazolidin-1-yl]-benzoic acid ethyl ester, promotes the retention of GLT-1 at the plasma membrane. Moreover, site-directed mutagenesis demonstrated the involvement of lysines 517 and 526 of GLT-1 in the constitutive internalization of the transporter. The translocation of GLT-1 from the recycling endosomes to the plasma membrane was blocked by LDN-57444, a specific inhibitor to the deubiquitinating enzyme (DUB) ubiquitin C-terminal hydrolase-L1, but not by an inhibitor of the related DUB ubiquitin C-terminal hydrolase-L3, supporting the existence of specific ubiquitination/deubiquitination cycles that ensure the correct concentrations of GLT-1 at the cell surface.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22593014     DOI: 10.1002/glia.22354

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  32 in total

1.  Amyloid-β1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1.

Authors:  Annalisa Scimemi; James S Meabon; Randall L Woltjer; Jane M Sullivan; Jeffrey S Diamond; David G Cook
Journal:  J Neurosci       Date:  2013-03-20       Impact factor: 6.167

Review 2.  Are glutamate transporters neuroprotective or neurodegenerative during cerebral ischemia?

Authors:  Li-Nan Zhang; Liang Hao; Yu-Song Guo; Hai-Yan Wang; Lin-Lin Li; Li-Zhe Liu; Wen-Bin Li
Journal:  J Mol Med (Berl)       Date:  2019-01-23       Impact factor: 4.599

Review 3.  Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Michael Aschner; Eunsook Y Lee
Journal:  Neurochem Res       Date:  2014-07-27       Impact factor: 3.996

4.  Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes.

Authors:  Irma E Cisneros; Anuja Ghorpade
Journal:  Neuropharmacology       Date:  2014-06-17       Impact factor: 5.250

5.  Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization.

Authors:  E Foran; L Rosenblum; A Bogush; P Pasinelli; D Trotti
Journal:  Glia       Date:  2014-04-21       Impact factor: 7.452

6.  Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal.

Authors:  Ronald Kim; Marian T Sepulveda-Orengo; Kati L Healey; Emily A Williams; Kathryn J Reissner
Journal:  Neuropharmacology       Date:  2017-09-14       Impact factor: 5.250

7.  Ceftriaxone Protects Astrocytes from MPP(+) via Suppression of NF-κB/JNK/c-Jun Signaling.

Authors:  Yunlong Zhang; Xiuping Zhang; Shaogang Qu
Journal:  Mol Neurobiol       Date:  2014-08-12       Impact factor: 5.590

8.  Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease.

Authors:  Carmen Muñoz-Ballester; Arnaud Berthier; Rosa Viana; Pascual Sanz
Journal:  Biochim Biophys Acta       Date:  2016-03-11

9.  Deletion of mTOR in Reactive Astrocytes Suppresses Chronic Seizures in a Mouse Model of Temporal Lobe Epilepsy.

Authors:  Xueqin Wang; Longze Sha; Nannan Sun; Yan Shen; Qi Xu
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

Review 10.  Glutamate Neurotransmission in Rodent Models of Traumatic Brain Injury.

Authors:  Christopher R Dorsett; Jennifer L McGuire; Erica A K DePasquale; Amanda E Gardner; Candace L Floyd; Robert E McCullumsmith
Journal:  J Neurotrauma       Date:  2016-07-06       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.